Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.

Abstract

BACKGROUND In the United Kingdom, the 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended in addition to routine pneumococcal conjugate vaccination for at-risk children aged ≥2 years. This study describes the epidemiology, serotype distribution, clinical characteristics, vaccination status, and reasons for nonvaccination in children aged 5… (More)
DOI: 10.1093/cid/cit791

Topics

6 Figures and Tables

Cite this paper

@article{Ladhani2014InvasivePD, title={Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.}, author={Shamez N Ladhani and Nick J. Andrews and Pauline Waight and Ray Borrow and Mary P. E. Slack and Elizabeth Miller}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2014}, volume={58 4}, pages={517-25} }